Baby bison appear to have a blast chasing each other at Yellowstone National Park ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

FTSE called higher as UK GDP growth weakens The FTSE 100 is predicted to continue rising towards 10,000 on Thursday, as the pound slipped ...

FTSE 100 falls 37 points to 9,874 UK GDP growth slows due to JLR cyberattack Results out from Rolls-Royce, Aviva, Burberry and many more 10.16am: ...